Cargando…

Treatment with the Immunomodulator AIC649 in Combination with Entecavir Produces Antiviral Efficacy in the Woodchuck Model of Chronic Hepatitis B

As current interventions for chronic hepatitis B (CHB) rarely induce cure, more effective drugs are needed. Short-term treatment of woodchucks with the novel immunomodulator AIC649, a parapoxvirus-based stimulator of toll-like receptor 9 dependent and independent pathways, has been shown to reduce v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Korolowicz, Kyle E., Suresh, Manasa, Li, Bin, Huang, Xu, Yon, Changsuek, Leng, Xuebing, Kallakury, Bhaskar V., Tucker, Robin D., Menne, Stephan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069054/ https://www.ncbi.nlm.nih.gov/pubmed/33918831 http://dx.doi.org/10.3390/v13040648

Ejemplares similares

Antiviral Efficacy and Host Immune Response Induction during Sequential Treatment with SB 9200 Followed by Entecavir in Woodchucks
por: Suresh, Manasa, et al.
Publicado: (2017)

Efficacy of an Inhibitor of Hepatitis B Virus Expression in Combination With Entecavir and Interferon‐α in Woodchucks Chronically Infected With Woodchuck Hepatitis Virus
por: Menne, Stephan, et al.
Publicado: (2020)

Combination Treatment with the Vimentin-Targeting Antibody hzVSF and Tenofovir Suppresses Woodchuck Hepatitis Virus Infection in Woodchucks
por: Korolowicz, Kyle E., et al.
Publicado: (2021)

AIC649 Induces a Bi-Phasic Treatment Response in the Woodchuck Model of Chronic Hepatitis B
por: Paulsen, Daniela, et al.
Publicado: (2015)

Liver‐Targeted Toll‐Like Receptor 7 Agonist Combined With Entecavir Promotes a Functional Cure in the Woodchuck Model of Hepatitis B Virus
por: Korolowizc, Kyle E., et al.
Publicado: (2019)

Antiviral Efficacy and Host Innate Immunity Associated with SB 9200 Treatment in the Woodchuck Model of Chronic Hepatitis B
por: Korolowicz, Kyle E., et al.
Publicado: (2016)

Toll-Like Receptor 7 Agonist RG7854 Mediates Therapeutic Efficacy and Seroconversion in Woodchucks With Chronic Hepatitis B
por: Wildum, Steffen, et al.
Publicado: (2022)

Innate and adaptive immunity associated with resolution of acute woodchuck hepatitis virus infection in adult woodchucks
por: Suresh, Manasa, et al.
Publicado: (2019)

Agonistic Activation of Cytosolic DNA Sensing Receptors in Woodchuck Hepatocyte Cultures and Liver for Inducing Antiviral Effects
por: Suresh, Manasa, et al.
Publicado: (2021)

Suitability of the woodchuck HCC as a preclinical model for evaluation of intra‐arterial therapies
por: Kim, Alexander Y., et al.
Publicado: (2020)

Recent Drug Development in the Woodchuck Model of Chronic Hepatitis B
por: Suresh, Manasa, et al.
Publicado: (2022)

Application of the woodchuck animal model for the treatment of hepatitis B virus-induced liver cancer
por: Suresh, Manasa, et al.
Publicado: (2021)

Involvement of Innate Immune Receptors in the Resolution of Acute Hepatitis B in Woodchucks
por: Suresh, Manasa, et al.
Publicado: (2021)

Toll‐Like Receptor 8 Agonist GS‐9688 Induces Sustained Efficacy in the Woodchuck Model of Chronic Hepatitis B
por: Daffis, Stephane, et al.
Publicado: (2020)

Therapeutic vaccination and immunomodulation in the treatment of chronic hepatitis B: preclinical studies in the woodchuck
por: Kosinska, Anna D., et al.
Publicado: (2014)

Combination of DNA Prime – Adenovirus Boost Immunization with Entecavir Elicits Sustained Control of Chronic Hepatitis B in the Woodchuck Model
por: Kosinska, Anna D., et al.
Publicado: (2013)

Molecular characterization of woodchuck IFI16 and AIM2 and their expression in woodchucks infected with woodchuck hepatitis virus (WHV)
por: Yan, Qi, et al.
Publicado: (2016)

Enzyme‐altered Liver Cell Foci in Woodchucks Infected with Woodchuck Hepatitis Virus
por: Abe, Kenji, et al.
Publicado: (1988)

Prevention of liver tumor formation in woodchucks with established hepatocellular carcinoma by treatment with cationic liposome-DNA complexes
por: Fairman, Jeffery, et al.
Publicado: (2017)

Cryo-EM structures of human hepatitis B and woodchuck hepatitis virus small spherical subviral particles
por: Liu, Haitao, et al.
Publicado: (2022)

Post-operative AICS status in completely resected lung cancer patients with pre-operative AICS abnormalities: predictive significance of disease recurrence
por: Anayama, Takashi, et al.
Publicado: (2018)

New beam extraction system for the AIC-144 cyclotron
por: Borisov, O N, et al.
Publicado: (1998)

Immune Effects of Cryoablation in Woodchuck Hepatocellular Carcinoma
por: Mauda-Havakuk, Michal, et al.
Publicado: (2023)

Safety and efficacy of anti-PD-L1 therapy in the woodchuck model of HBV infection
por: Balsitis, Scott, et al.
Publicado: (2018)

Feasibility study of the beam extraction from the AIC-144 cyclotron
por: Borisov, O N, et al.
Publicado: (1996)

The Genome Sequence of the Eastern Woodchuck (Marmota monax) – A Preclinical Animal Model for Chronic Hepatitis B
por: Alioto, Tyler S., et al.
Publicado: (2019)

Antiviral Efficacy of Entecavir versus Entecavir plus Adefovir for Hepatitis B Virus rtA181V/T Mutants Alone
por: Oh, Myung Jin, et al.
Publicado: (2016)

Antiviral and Immunomodulation Effects of Artemisia
por: Kshirsagar, Suhas G., et al.
Publicado: (2021)

Comparing Dynamic Causal Models using AIC, BIC and Free Energy
por: Penny, W.D.
Publicado: (2012)

Model Averaging with AIC Weights for Hypothesis Testing of Hormesis at Low Doses
por: Kim, Steven B., et al.
Publicado: (2017)

Abstracts: PICS-AICS Virtual Symposium September 10–12, 2020
Publicado: (2020)

A multicentre clinical validation of AminoIndex Cancer Screening (AICS)
por: Mikami, Haruo, et al.
Publicado: (2019)

Over the Limits of Traditional Sampling: Advantages and Issues of AICs for Measurement Instrumentation
por: Iadarola, Grazia, et al.
Publicado: (2023)

Intrahepatic Transcriptional Signature Associated with Response to Interferon-α Treatment in the Woodchuck Model of Chronic Hepatitis B
por: Fletcher, Simon P., et al.
Publicado: (2015)

Therapeutic Vaccination in Chronic Hepatitis B: Preclinical Studies in the Woodchuck
por: Kosinska, Anna D., et al.
Publicado: (2010)

Persistence of the Recombinant Genomes of Woodchuck Hepatitis Virus in the Mouse Model
por: Pan, Danzhen, et al.
Publicado: (2015)

A novel hepatovirus identified in wild woodchuck Marmota himalayana
por: Yu, Jie-mei, et al.
Publicado: (2016)

Imaging, Pathology, and Immune Correlates in the Woodchuck Hepatic Tumor Model
por: Mauda-Havakuk, Michal, et al.
Publicado: (2021)

Combining immunomodulators and antivirals for COVID-19
por: Chen, Luke Y C, et al.
Publicado: (2021)

Safety of entecavir antiviral therapyduring an accidental pregnancy in patients with chronic hepatitis B
por: Cao, Lihua, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_crjmrgab63skd3oor6cc6aligb